Skip to main content
. Author manuscript; available in PMC: 2013 Dec 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2007 Apr 12;61(2):10.1007/s00280-007-0472-1. doi: 10.1007/s00280-007-0472-1

Fig. 2.

Fig. 2

The Kaplan–Meier estimate of overall survival in the 51 patients with metastatic colorectal cancer enrolled on the study. The dashed lines represent the 95% confidence interval (CI) about each successive estimate of the survival rate. The median survival was 21.2 months [95% CI, 13.8-not available months]. The 1-year survival rate was 75% (95% CI, 0.63–0.88). The 2-year survival rate was 48% (95% CI, 0.31–0.64)